TrialNaunyn-Schmiedeberg's archives of pharmacology2010

Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation.

Niels Voigt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.